SAB Biotherapeutics Provides Company Update for Q3 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. ENOV
6. AON
7. AZN
8. AAPL
9. BLSM
10. GPRO

Go back to SAB Biotherapeutics Provides Company Update for Q3 2022 Financial Results
(NASDAQ: SABS) Delayed: 3.73 +0.02 (0.54%)
Previous Close $3.71    52 Week High $ 
Open $3.65    52 Week Low $ 
Day High $3.75    P/E N/A 
Day Low $3.65    EPS $ 
Volume 120,876       

(NASDAQ: SABSW) Delayed: 0.02 --0 (-0%)
Previous Close $0.02    52 Week High $ 
Open $0.02    52 Week Low $ 
Day High $0.03    P/E N/A 
Day Low $0.02    EPS $ 
Volume 1,407